COPENHAGEN (Reuters) – Enzymes maker Novozymes on Tuesday reported fourth quarter operating profit slightly below expectations but said it expected sales to grow organically by between 3-7% in the next financial year.
The Danish company said fourth quarter earnings before interest and tax came in at 805 million Danish crowns ($121.60 million), below an average estimate of 844 million forecast by analysts in a Refinitiv poll.
($1 = 6.6200 Danish crowns)
(Reporting by Nikolaj Skydsgaard; Editing by Kirsten Donovan)
